Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Shinzo, Takamori"'
Autor:
Shintaro Yokoyama, Masahiro Mitsuoka, Tetsushi Kinugasa, Toshihiro Hashiguchi, Ryoichi Matsumoto, Daigo Murakami, Tatsuya Nishi, Koichi Yoshiyama, Masaki Kashihara, Shinzo Takamori, Yoshito Akagi
Publikováno v:
BMC Surgery, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background A clear survival benefit has been reported for lung metastasectomy for colorectal cancer, and several clinicopathological prognostic factors have been proposed in the past. However, clinical advances, such as chemotherapy and radi
Externí odkaz:
https://doaj.org/article/525b60dcdecf40ca9f9377d29b4fdda8
Autor:
Koichi Ohshima, Yoshito Akagi, Shinzo Takamori, Masahiro Mitsuoka, Toshihiro Hashiguchi, Joji Shimono, Kazutaka Nakashima, Hiroaki Miyoshi, Shintaro Yokoyama
Supplementary Table S2. Multivariate analysis for prognostic factors affecting overall survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a1d832056947eb7c2adfe3bcf9911ad
https://doi.org/10.1158/1078-0432.22462866.v1
https://doi.org/10.1158/1078-0432.22462866.v1
Autor:
Isamu Okamoto, Yoichi Nakanishi, Tomoaki Hoshino, Masayoshi Kage, Shinzo Takamori, Koichi Takayama, Koichiro Matsumoto, Taishi Harada, Junko Tanizaki, Eiji Iwama, Satoshi Hattori, Akihiko Kawahara, Koichi Azuma, Keiichi Ota
Purpose: Therapies targeted to the immune checkpoint mediated by PD-1 and PD-L1 show antitumor activity in a subset of patients with non–small cell lung cancer (NSCLC). We have now examined PD-L1 expression and its regulation in NSCLC positive for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a749d3f870055d7c840ac8f21b2138ea
https://doi.org/10.1158/1078-0432.c.6523667.v1
https://doi.org/10.1158/1078-0432.c.6523667.v1
Autor:
Isamu Okamoto, Yoichi Nakanishi, Tomoaki Hoshino, Masayoshi Kage, Shinzo Takamori, Koichi Takayama, Koichiro Matsumoto, Taishi Harada, Junko Tanizaki, Eiji Iwama, Satoshi Hattori, Akihiko Kawahara, Koichi Azuma, Keiichi Ota
Supplementary Table S1. Patient characteristics
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32be92df87722426c46ea4095f0b1621
https://doi.org/10.1158/1078-0432.22457708
https://doi.org/10.1158/1078-0432.22457708
Autor:
Koichi Ohshima, Yoshito Akagi, Shinzo Takamori, Masahiro Mitsuoka, Toshihiro Hashiguchi, Joji Shimono, Kazutaka Nakashima, Hiroaki Miyoshi, Shintaro Yokoyama
Purpose: The immune checkpoint of the programmed death 1/programmed death ligand 1 (PD-1/PD-L1) pathway is believed to play an important role in evasion of host antitumor immune surveillance in various malignancies; however, little is known about its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf3798e60e839eccc438f9c01d2b3bae
https://doi.org/10.1158/1078-0432.c.6525237.v1
https://doi.org/10.1158/1078-0432.c.6525237.v1
Autor:
Isamu Okamoto, Yoichi Nakanishi, Tomoaki Hoshino, Masayoshi Kage, Shinzo Takamori, Koichi Takayama, Koichiro Matsumoto, Taishi Harada, Junko Tanizaki, Eiji Iwama, Satoshi Hattori, Akihiko Kawahara, Koichi Azuma, Keiichi Ota
Supplementary Figure S3. Effects of AKT and ERK depletion on PD-L1 expression in EML4-ALK fusion-positive (H3122) cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c751e6271a1e078e693b6ac77236c8b4
https://doi.org/10.1158/1078-0432.22457714.v1
https://doi.org/10.1158/1078-0432.22457714.v1
Autor:
Isamu Okamoto, Yoichi Nakanishi, Tomoaki Hoshino, Masayoshi Kage, Shinzo Takamori, Koichi Takayama, Koichiro Matsumoto, Taishi Harada, Junko Tanizaki, Eiji Iwama, Satoshi Hattori, Akihiko Kawahara, Koichi Azuma, Keiichi Ota
Supplementary Figures legends. Supplementary Figures legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b7a75c844eb2aa4c6cc4f78280f10c1
https://doi.org/10.1158/1078-0432.22457711
https://doi.org/10.1158/1078-0432.22457711
Autor:
Koichi Takayama, Shunichi Sugawara, Yasuo Saijo, Makoto Maemondo, Atsushi Sato, Shinzo Takamori, Taishi Harada, Tetsuro Sasada, Tatsuyuki Kakuma, Junji Kishimoto, Akira Yamada, Masanori Noguchi, Kyogo Itoh, Yoichi Nakanishi
Publikováno v:
Journal of Immunology Research, Vol 2016 (2016)
Objectives. To evaluate the efficacy and safety of personalized peptide vaccination (PPV) combined with chemotherapy for patients with previously treated advanced non-small-cell lung cancer (NSCLC). Patients and Methods. Previously treated PS0-1 pati
Externí odkaz:
https://doaj.org/article/63b25f2fda2442d389ea8c13949a9802
Autor:
Shinzo Takamori, Hidenobu Ishii, Kazuhiro Tabata, Shuji Nagata, Akiko Sumi, Kiminori Fujimoto, Tomonori Chikasue, Junya Fukuoka, Kenji Izuhara, Shoichiro Ohta, Shuichi Tanoue, Daigo Murakami, Masamichi Koganemaru, Ryoji Iwamoto, Koichi Ohshima, Toshi Abe
Publikováno v:
Molecular and Clinical Oncology
Adenocarcinoma is the most common histological type of non-small cell lung cancer (NSCLC), and various biomarkers for predicting its prognosis after surgical resection have been suggested, particularly in early-stage lung adenocarcinoma. Periostin (a
Autor:
Toshihiro Hashiguchi, Ryoichi Matsumoto, Koichi Yoshiyama, Daigo Murakami, Tatsuya Nishi, Masaki Kashihara, Shinzo Takamori, Yoshito Akagi, Hirofumi Ono, Masahiro Mitsuoka, Shintaro Yokoyama
Publikováno v:
International Journal of Surgery Case Reports
Highlights • Anterior mediastinal tumors often cause airway compression. • General anesthesia for a tumor biopsy can cause fatal airway obstruction. • Temporary stenting can prevent fatal airway obstruction in anesthetized patients.
Introd
Introd